XML 36 R20.htm IDEA: XBRL DOCUMENT
v3.25.1

STOCK COMPENSATION PLANS | 3 Months Ended
--- | ---
Mar. 30, 2025
Share-Based Payment Arrangement [Abstract] |
STOCK COMPENSATION PLANS | STOCK COMPENSATION PLANS Share-based grants for compensation and incentive purposes are made pursuant to the Equity and Incentive Compensation Plan (“EICP”). The EICP provides for grants of one or more of the following stock-based compensation awards to employees, non-employee directors and certain service providers upon whom the successful conduct of our business is dependent: •Non-qualified stock options (“stock options”); •Performance stock units (“PSUs”) and performance stock; •Stock appreciation rights; •Restricted stock units (“RSUs”) and restricted stock; and •Other stock-based awards. The EICP also provides for the deferral of stock-based compensation awards by participants if approved by the Compensation and Human Capital Committee of our Board and if in accordance with an applicable deferred compensation plan of the Company. Currently, the Compensation and Human Capital Committee has authorized the deferral of PSU and RSU awards by certain eligible employees under the Company’s Deferred Compensation Plan. Our Board has authorized our non-employee directors to defer any portion of their cash retainer, committee chair fees and RSUs awarded that they elect to convert into deferred stock units under our Directors’ Compensation Plan. At the time stock options are exercised or PSUs and RSUs become payable, Common Stock is issued from our accumulated treasury shares. Dividend equivalents are credited on RSUs on the same date and at the same rate as dividends paid on our Common Stock. Dividend equivalents are charged to retained earnings and included in accrued liabilities until paid. Awards to employees eligible for retirement prior to the award becoming fully vested are amortized to expense over the period through the date that the employee first becomes eligible to retire and is no longer required to provide service to earn the award. In addition, historical data is used to estimate forfeiture rates and record share-based compensation expense only for those awards that are expected to vest. For the periods presented, compensation expense for all types of stock-based compensation programs and the related income tax benefit recognized were as follows:
|  |  |  | Three Months Ended
|  |  |  |  |  | March 30, 2025 |  | March 31, 2024
Pre-tax compensation expense |  |  |  |  |  | $ | 13,559 |  |  | $ | 5,986 |
Related income tax benefit |  |  |  |  |  | 3,308 |  |  | 1,221 |
Compensation expenses for stock compensation plans are primarily included in SM&A expense. As of March 30, 2025, total stock-based compensation expense related to non-vested awards not yet recognized was $105,959 and the weighted-average period over which this amount is expected to be recognized was approximately 2.1 years. Stock Options The exercise price of each stock option awarded under the EICP equals the closing price of our Common Stock on the New York Stock Exchange on the date of grant. Each stock option has a maximum term of 10 years. Grants of stock options provide for pro-rated vesting, typically over a four-year period. Expense for stock options is based on grant date fair value and recognized on a straight-line method over the vesting period, net of estimated forfeitures. A summary of activity relating to grants of stock options for the period ended March 30, 2025 is as follows:
Stock Options | Shares | Weighted-Average Exercise Price (per share) | Weighted-Average Remaining Contractual Term | Aggregate Intrinsic Value
Outstanding at beginning of year | 579,834 |  | $106.73 | 2.7 years |
Exercised | (30,277) |  | $101.12 |  |
Outstanding as of March 30, 2025 | 549,557 |  | $107.04 | 2.5 years | $ | 35,081 |
Options exercisable as of March 30, 2025 | 544,098 |  | $105.93 | 2.4 years | $ | 35,081 |
No options were granted for the period ended March 30, 2025. The weighted-average fair value of options granted was $45.95 per share for the period ended March 31, 2024. The fair value was estimated on the date of grant using a Black-Scholes option-pricing model and the following weighted-average assumptions:
|  |  |  | Three Months Ended
|  |  |  | March 31, 2024
Dividend yields |  |  |  | 2.0 | %
Expected volatility |  |  |  | 21.3 | %
Risk-free interest rates |  |  |  | 4.3 | %
Expected term in years |  |  |  | 6.3
The total intrinsic value of options exercised was $1,833 and $4,148 for the periods ended March 30, 2025 and March 31, 2024, respectively. Performance Stock Units and Restricted Stock Units Under the EICP, we grant PSUs to select executives and other key employees. Vesting is contingent upon the achievement of certain performance objectives. We grant PSUs over three-year performance cycles. If we meet targets for financial measures at the end of the applicable three-year performance cycle, we award a resulting number of shares of our Common Stock to the participants. The number of shares may be increased to the maximum or reduced to the minimum threshold based on the results of these performance metrics in accordance with the terms established at the time of the award. For PSUs granted, the target award is a combination of a market-based total shareholder return and performance-based components. For market-based condition components, market volatility and other factors are taken into consideration in determining the grant date fair value and the related compensation expense is recognized regardless of whether the market condition is satisfied, provided that the requisite service has been provided. For performance-based condition components, we estimate the probability that the performance conditions will be achieved each quarter and adjust compensation expenses accordingly. The performance scores of PSU grants during the three months ended March 30, 2025 and March 31, 2024 can range from 0% to 250% of the targeted amounts. We recognize the compensation expenses associated with PSUs ratably over the three-year term. Compensation expenses are based on the grant date fair value because the grants can only be settled in shares of our Common Stock. The grant date fair value of PSUs is determined based on the Monte Carlo simulation model for the market-based total shareholder return component and the closing market price of the Company’s Common Stock on the date of grant for performance-based components. During the three months ended March 30, 2025 and March 31, 2024, we awarded RSUs to certain executive officers and other key employees under the EICP. We also awarded RSUs to non-employee directors. We recognize the compensation expenses associated with employee RSUs over a specified award vesting period based on the grant date fair value of our Common Stock. We recognize expense for employee RSUs based on the straight- line method. The compensation expenses associated with non-employee director RSUs is recognized ratably over the vesting period, net of estimated forfeitures. A summary of activity relating to grants of PSUs and RSUs for the period ended March 30, 2025 is as follows:
Performance Stock Units and Restricted Stock Units |  | Number of units |  | Weighted-average grant date fair value for equity awards (per unit)
Outstanding at beginning of year |  | 538,803 |  |  | $204.65
Granted |  | 420,478 |  |  | $166.02
Performance assumption change (1) |  | 79,674 |  |  | $268.24
Vested |  | (273,976) |  |  | $207.25
Forfeited |  | (27,134) |  |  | $204.08
Outstanding as of March 30, 2025 |  | 737,845 |  |  | $188.55
(1)Reflects the net number of PSUs above and below target levels based on the performance metrics. The following table sets forth information about the fair value of the PSUs and RSUs granted for potential future distribution to employees and non-employee directors. In addition, the table provides assumptions used to determine the fair value of the market-based total shareholder return component using the Monte Carlo simulation model on the date of grant.
|  | Three Months Ended
|  | March 30, 2025 |  | March 31, 2024
Units granted |  | 420,478 |  | 315,389
Weighted-average fair value at date of grant |  | $ | 166.02 |  | $ | 196.16
Monte Carlo simulation assumptions: |  |  |  |
Estimated values |  | $ | 65.27 |  | $ | 84.13
Dividend yields |  | 3.3 | % |  | 2.8 | %
Expected volatility |  | 21.7 | % |  | 18.5 | %
The fair value of shares vested totaled $46,251 and $84,998 for the periods ended March 30, 2025 and March 31, 2024, respectively. Deferred PSUs, deferred RSUs and deferred stock units representing directors’ fees totaled 244,525 units as of March 30, 2025. Each unit is equivalent to one share of the Company’s Common Stock.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/718/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (l) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration